John Sullivan-Bolyai
Vice President, Clinical Research
« Back to Executive Management
John Z. Sullivan-Bólyai, M.D., M.P.H has served as vice president of clinical research at Idenix since July 2007. Prior to joining Idenix, Dr. Sullivan-Bólyai, most recently held leadership positions with Anadys Pharmaceuticals and Valeant Pharmaceuticals where he was responsible for the planning and implementation clinical research activities in Hepatitis C and Hepatitis B. His broad clinical development experience includes HIV, endocrinology, hepatology and coagulation. Dr. Sullivan-Bólyai holds an A.B. degree from Dartmouth College. He received his M.D. and M.P.H. degrees from the University of Washington, Seattle, WA. He completed his infectious diseases fellowship training at Children's Orthopedic Hospital and Medical Center, Seattle, WA.
Idenix has focused its efforts towards HCV due to the global unmet medical need for this viral disease. It is estimated that more than 170 million people worldwide are chronically infected with HCV.